Multi-Cancer Screening: New Era or New Dilemma?
Speaker:
Geoffrey Baird MD, PhD, Professor and Chair, Department of Laboratory Medicine and Pathology, University of Washington
Contact Hours:
1.0
Date:
September 28, 2026 - September 30, 2027
Description:
Can a single blood test screen for multiple cancers at once and improve patient outcomes through earlier detection? Dr. Geoff Baird from the University of Washington explores the promise and limitations of multi-cancer early detection (MCED) tests, how they compare with established screening methods, and what current research reveals about their potential benefits, harms, and costs.
Learning Objectives:
- Describe the concepts of sensitivity, positive and negative predictive value, and Number Needed to Screen, in the context of cancer screening tests
- Compare and contrast several features of traditional cancer screening programs and MCED-based cancer screening tests
- Describe the calculation of an Incremental Cost-Effectiveness Ratio, expressed in Dollars per Quality-Adjusted Life Year